¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acute disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • pandemic disease
    ¹üÀ¯Çິ
  • pneumatic hammer disease
    ¾ÐÂø°ø±âÇØ¸Óº´
  • polycystic kidney disease
    ´Ù³¶½ÅÀ庴, ¹µÁÖ¸Ó´ÏÄáÆÏº´
  • panzootic disease
    µ¿¹°¹üÀ¯Çິ
  • posttransplant lymphoproliferative disease
    À̽ÄÈĸ²ÇÁ¼¼Æ÷Áõ½Äº´
  • prenatal disease
    Ãâ»ýÀüº´
  • primary cholestatic liver disease
    ¿ø¹ß¾µ°³ÁóÁ¤Ã¼°£Áúȯ, ¿ø¹ß´ãÁóÁ¤Ã¼°£Áúȯ
  • primary pigmented nodular adrenocortical disease
    ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½Å°ÑÁúº´, ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½ÅÇÇÁúº´
  • professional disease
    Àü¹®Á÷¾÷º´, Á÷¾÷º´
  • protozoan disease
    ¿øÃ溴
  • psychosomatic disease
    Á¤½Å½Åüº´
  • pulseless disease
    ¹«¸Æ¹Úº´
  • pyramidal disease
    ÇǶó¹Ìµå½Å°æ·Îº´, Ãßü·Îº´
  • Paget¡¯s disease
    ÆÄÁ¦Æ®º´
  • parasitic disease
    1. ±â»ýÃæº´ 2. ±â»ýÃæÁúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • spinocerebellar disease
    ô¼ö¼Ò³úº´
  • spirochetal disease
    ½ºÇÇ·ÎÇ쟺´
  • sterility disease
    ºÒÀÓº´
  • storage disease
    ÃàÀûº´
  • subclinical disease
    ºÒÇö¼ºº´
  • systemic disease
    Àü½Åº´
  • thoracic disease
    °¡½¿º´, ÈäºÎÁúȯ
  • tick-borne disease
    Áøµå±â¸Å°³º´
  • trophoblastic disease
    ¿µ¾ç¸·º´
  • tropical disease
    ¿­´ëº´
  • tsutsugamushi disease
    ÂêÂê°¡¹«½Ãº´
  • tubulointerstitial disease
    ¿ä¼¼°ü»çÀÌÁúÁúȯ, ¿ä¼¼°ü°£Áúº´
  • upper respiratory disease
    »ó±âµµº´
  • uremic medullary cystic disease
    ¿äµ¶¼ÓÁú³¶º´
  • valvular heart disease
    ÆÇ¸·½ÉÀ庴
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Crohns disease
    Å©·Ðº´
  • Crohns disease
    Å©·Ðº´.
  • Crouzons disease =craniofacial dysostosis
    µÎ°³¾È¸éȸ°ñºÎÀüÁõ, Å©·ç Á¾º´ µÎ°³¾È¸éÀ̰ñÁõ .
  • Cushings disease
    Äí½Ìº´.
  • Dariers disease => keratosis follicularis
    ´Ù¸®¿¡ º´
  • Degenerative disease
    ÅðÇ༺Áúȯ
  • Dego s disease
    µ¥°íº´.
  • Dejerine-Sottas disease
    µ¥Á¦¸°-¼ÚŸº´.
  • Dercums disease
    ´õÄĺ´
  • Detergent workers disease
    ¼¼Á¤Á¦Ãë±ÞÀÚÁúȯ
  • Devics disease=>optic neuromyelitis
    µ¥ºòº´
  • Di Guglielmos disease
    µð±¸±Û¸®¿¤¸ðº´, ÀûÇ÷º´¼º °ñ¼öÁõ.
  • Dorfman-Chanarin syndrome = neutral lipid storage disease
    Áß¼ºÁö¹æÃàÀûÁõ
  • Dowling-Degos disease = reticular pigmented anomaly of the flexures
    ±¼ÃøºÎ ¸Á»ó»ö¼ÒÀÌ»ó(Áõ)
  • Duhrings disease => dermatitis herpetiformis
    Æ÷Áø»ó ÇǺο°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • air pilots disease
    ºñÇàÁ¶Á¾»çº´.
  • air space disease
    °ø±â °ø°£ Áúȯ
  • aircraft disease
    Ç×°øº´.
  • albers-sch berg disease
    ¾Ëº£¸£½º-½¨º£¸£Å© º´(¡­Ü»)
  • albers-schonberg disease
    ¾Ëº£¸£½º-½¨º£¸£Å©º´(¡­Ü»)
  • alcoholic liver disease
    ¾ËÄڿüº °£Áúȯ(¡­àõ ÊÜòðü´)
  • alexanders disease
    ¾Ë·º»ê´õ º´(¡­Ü»)
  • alkali disease =alkalosis
    ¾ËÄ®¸®º´ ¾ËÄ®¸®(Ç÷)Áõ .
  • allergic disease
    ¾Ë·¹¸£±â¼º Áúȯ, ¾Ë·¹¸£±âº´
  • allergic disease
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
  • allergic skin disease
    ¾Ë·¹¸£±â(¼º)ÇǺΠÁúȯ
  • allergic skin disease
    ¾Ë·¹¸£±â[¼º] ÇǺκ´
  • alpha (¥á) chain disease
    ¾ËÆÄ»ç½½º´, ¾ËÆÄ¼âº´
  • alpha chain disease
    ¾ËÆÄ¼âº´(¡­áðÜ»).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
RHD radiological health data; relative hepatic dullness; renal hypertensive disease; rheumatic heart dis...
SCD scleroderma; service-connected disability; sickle-cell disease; spinocerebellar degeneration; subacu...
SMCD senile macular choroidal degeneration; systemic mast cell disease; systemic meningococcal disease
URD unspecified respiratory disease; upper respiratory disease
VD vapor density; vascular disease; vasodilation, vasodilator; venereal disease; venous dilatation; ven...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
ARN Acute retinal necrosis
ARN Acute retinal necrosis syndrome
ASDH Acute subdural hematoma
ATM Acute transverse myelitis
ATM Acute transverse myelopathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • manager disease
    ¸Å´ÏÀú º´
    ¿©·¯ °¡Áö º¹ÀâÇÑ ¾÷¹«¿¡ ¹Ù»Ú°Ô ½Ã´Þ¸®´Â °ü¸® Á÷±ÞÀÇ »ç¶÷¿¡°Ô¼­ ÈçÈ÷ º¼ ¼ö ÀÖ´Â º´. Çù½ÉÁõ, ƯÈ÷ °ü»ó µ¿¸Æ Ç÷ÀüÁõ µîÀÇ ½ÉÀå Ç÷°ü°è Áõ¼¼µé¸¸À» °¡¸®Å°´Â °ÍÀ̾ú´Âµ¥ Á¡Â÷·Î È®´ëµÇ¾î ¼ÒÈ­¼º ±Ë¾ç, ´ç´¢º´, ³ëÀÌ·ÎÁ¦, Ç÷¾Ð Àå¾Ö µîµµ Æ÷ÇԵȴÙ.
  • maple syrum urine disease
    ´Üdz ³ª¹« ½Ã·´ º´
    Ãø¼â, ¾Æ¹Ì³ë»ê ´ë»çÀÇ È¿¼Ò °á¼Õ¿¡ ÀÇÇÑ À¯Àüº´À¸·Î, Ç÷Àå ¹× ¿äÁß¿¡¼­ ŰÅä»ê
  • maple syrup urine disease
    ´Üdz ´ç¹Ð ´¢ Áúȯ
    Ãø¼â ¾Æ¹Ì³ë»ê ´ë»çÀÇ È¿¼Ò °á¼Õ¿¡ ÀÇÇÑ À¯Àüº´À¸·Î, Ç÷Àå ¹× ¿äÁß¿¡¼­ ŰÅä»ê[valine, leucine, isoleucine]ÀÇ ½ÉÇÑ Áõ°¡¸¦ º¼ ¼ö ÀÖ´Ù. ÀÓ»óÀû Ư¡Àº Á¤½Å Áöü ¹ß´Þ Áö¿¬, Æ÷À¯ °ï¶õ, ¿äÃë µîÀÌ´Ù.
  • marble bone disease
    °ñ È­¼®Áõ, ´ë¸®¼® °ñº´
    ´ß ¹éÇ÷º´ À°Á¾±º¿¡ ¼ÓÇÏ´Â º´. °ñÇü ¸²ÇÁÁ¾À̶ó°íµµ ÇÏ´Â ÀÌ º´Àº, »À°¡ ±½¾îÁö´Â °ÍÀÌ Æ¯Â¡À̸ç, ¹ß»ýÀÌ µå¹°±â ¶§¹®¿¡ °æÁ¦ÀûÀ¸·Î Å« ¶æÀº ¾ø´Ù. Ç÷±¸¿Í ÀüÇô °ü°è¾øÀÌ »À ¼¼Æ÷°¡ Áõ½ÄÇϹǷΠÇ÷±¸¿¡¼­ À¯·¡ÇÏ´Â Á¾¾çÀÌ ¾Æ´Ï¶ó, ¹éÇ÷º´°ú °°Àº ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ ÀϾ´Â º´À̱⠶§¹®¿¡ ¹éÇ÷º´À¸·Î Ãë±ÞµÈ´Ù.
  • Marchiafava-Bignami disease
    ¸¶¸£Å°¾ÆÆÄ¹Ù-ºñ³Ä¹Ì º´
    ³ú·®ÀÇ ÁøÇ༺ ÅðÇà º¯¼ºÀ¸·Î¼­ ÁøÇ༺ ÁöÀû ȲÆó, Á¤¼­ Àå¾Ö, Âø¶õ, ȯ°¢, ÁøÀü, °­Á÷, °æ·ÃÀÌ Æ¯Â¡. ÁÖ·Î Á߳⠳²ÀÚ Áß ¾ËÄÝ Áßµ¶ÀÚ, ƯÈ÷ ´Ù·®ÀÇ »ýÆ÷µµÁÖ¸¦ ¸¶½Ã´Â »ç¶÷¿¡°Ô Àß °É¸®´Â µå¹® Áúº´ÀÌ´Ù.
  • Marek's disease
    ¸¶·¹Å© º´
    Æ÷Áø ¹ÙÀÌ·¯½º
  • margarine disease
    ¸¶°¡¸° º´
    ´ÙÇü¼º È«¹ÝÀ¸·Î¼­ oleomargarineÁßÀÇ À¯È­Á¦°¡ ¿øÀÎÀÌ´Ù. µ¶ÀÏ, ¿À¶õ´Ù¿¡¼­ Æø¹ßÀûÀ¸·Î À¯ÇàÇÏ¿´À¸¸ç ´ç½Ã´Â Àü¿°¼ºÀ̶ó°í »ý°¢Çß´Ù.
  • medullary cystic disease
    ¼öÁú³¶¼º Áúȯ
  • mental disease
    Á¤½Åº´
    ±â´ÉÀû ¿øÀΰú ±âÁúÀûÀÎ ¿øÀÎÀ» Æ÷ÇÔÇÑ ¸ðµç Á¤½Åº´.
  • metabolic bone disease
    ´ë»ç¼º °ñ Áúȯ
  • metabolic disease
    ´ë»ç¼º Áúȯ
    ½Åü ¼¼Æ÷ÀÇ È­ÇйÝÀÀÀÇ Àå¾Ö°¡ ¿øÀÎÀÌ µÇ´Â Áúȯ.
  • Mikulicz's disease
    ¹ÌŬ¸¯Âê¾¾º´, ¹ÌÄð¸®Ã÷º´
    ¹ÌÁöÀÇ ¿øÀο¡ ÀÇÇÑ ´©¼± ¹× Ÿ¾×¼±ÀÇ ¾ç¼º ÀÚ±â ÇÑÁ¤¼º ¸²ÇÁ±¸ ħÀ±°ú Á¾Ã¢À¸·Î¼­, Á߳⠶Ǵ ³ë³âÀÇ ºÎÀο¡°Ô ¹ßº´ÇÑ´Ù. Sjögren ÁõÈıº°ú µ¿ÀÏÇÏ´Ù°í »ý°¢ÇÏ´Â »ç¶÷µéµµ ÀÖ´Ù. ¶Ç´Â °øÅëÀÇ º´ÀÎÀ» °¡Áø µ¿ÀÏ ÁúȯÀÇ ÀÌÇüÀ̶ó°í ÇÏ´Â »ç¶÷µµ ÀÖ´Ù. À¯À°Á¾Áõ, ¾Ç¼º ¸²ÇÁÁ¾, ±³¿øº´ µî¿¡¼­ µ¿ÀÏÇÑ ÀÓ»ó ¼Ò°ßÀ» º¼ ¶§, Mikulicz ÁõÈıºÀ̶ó°í ÇÑ´Ù.
  • mitral valvular disease
    ½Â¸ðÆÇ¸· Áúȯ
  • molecular disease
    ºÐÀÚ º´
    Ç÷»ö¼Ò ºÐÀÚÀÇ ±Û·Îºó ÀÌ»ó¿¡ ÀÇÇÑ ÀÌ»ó Ç÷»ö¼ÒÀÇ Á¸Àç¿¡ ÀÇÇØ ¹ß»ýÇϴ Ư¼öÇÑ ºóÇ÷¿¡ ´ëÇÏ¿© PaulingÀÌ ºÙÀÎ ¸íĪ.
  • motor neuron disease
    ¿îµ¿ ´º·± Áúȯ
    ¿îµ¿ ½Å°æ¿ø¼º Áúȯ, ¿îµ¿ ½Å°æ ´º·±ÀÇ ÁúȯÀ¸·Î¼­ ô¼ö ½Å°æ À§Ãà, ÁøÇ༺ ±¸»ó ¸¶ºñ, ±ÙÀ§Ã༺ Ãà»è °æÈ­Áõ, Ãà»è °æÈ­Áõ µîÀ» ¸ðµÎ Æ÷ÇÔÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
Calve-Perthes disease perthes disease
camurati-engelmann disease <radiology> Sclerosing diaphyseal dysplasia, does not involve metaphysis, epiphysis, or bone marrow cavity Cf: Albers-Schoenberg disease
(12 Dec 1998)
canavan disease Spongy degeneration of cerebral white matter, a rare autosomal recessive form of leukodystrophy. It is characterised by early onset, widespread demyelination and vacuolation of the white matter that gives rise to a spongy appearance, severe mental retardation, megalocephaly, atony of the neck muscles, spasticity of the extremities, and blindness. Death occurs at about 18 months of age.
(12 Dec 1998)
Canavan's disease Autosomal recessive degenerative disease of infancy; mostly in Jewish infants; onset typically within first 3-4 months of birth, consisting of blindness, psychomotor regression, enlarged head, optic atrophy, hypotonia, spasticity, increased N-acetylaspartic acid urinary excretion. MRI shows enlarged brain, decreased attenuation of cerebral and cerebellar white matter, and normal ventricles. Pathologically, there is increased brain volume and weight, and spongy degeneration in the subcortical white matter.
See: leukodystrophy.
Synonym: Canavan's sclerosis, Canavan-van Bogaert-Bertrand disease, spongy degeneration of infancy.
(05 Mar 2000)
Canavan-van Bogaert-Bertrand disease Autosomal recessive degenerative disease of infancy; mostly in Jewish infants; onset typically within first 3-4 months of birth, consisting of blindness, psychomotor regression, enlarged head, optic atrophy, hypotonia, spasticity, increased N-acetylaspartic acid urinary excretion. MRI shows enlarged brain, decreased attenuation of cerebral and cerebellar white matter, and normal ventricles. Pathologically, there is increased brain volume and weight, and spongy degeneration in the subcortical white matter.
See: leukodystrophy.
Synonym: Canavan's sclerosis, Canavan-van Bogaert-Bertrand disease, spongy degeneration of infancy.
(05 Mar 2000)
cancer, hodgkin's disease A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia.
(12 Dec 1998)
canine parvovirus disease An acute disease of dogs with a variable mortality rate caused by the canine parvovirus; seen in three distinct clinical forms; a generalised neonatal disease, a severe nonsuppurative myocarditis, and a frequently fatal enteritis.
(05 Mar 2000)
carcinoid heart disease Cardiac manifestation of malignant carcinoid syndrome. It is a unique form of fibrosis involving the endocardium, primarily of the right heart. The fibrous deposits tend to cause constriction of the tricuspid and pulmonary valves.
(12 Dec 1998)
caroli disease <radiology> Communicating, cavernous ectasia of the intrahepatic bile ducts, rare, autosomal recessive, usually detected in young adults, no cirrhosis or portal hypertension, predisposed to calculus formation, benign course, but.. Recurrent cholangitis most likely to be liver abscesses most likely to be death, associated with medullary sponge kidney (renal tubular ectasia) in 80%
(12 Dec 1998)
caroli's disease Congenital cystic dilatation of the intrahepatic bile ducts. It consists of 2 types: simple, with bile duct dilatation or ectasia alone, and complex, with associated extensive hepatic fibrosis and portal hypertension. Benign renal tubular ectasia is associated with both types.
(12 Dec 1998)
rabbit haemorrhagic disease A highly infectious disease of rabbits, caused by a calicivirus and characterised by haemorrhagic lesions, particularly affecting the lungs and liver; since it was first identified in China in 1984, it has been reported from Korea, it has spread through Europe, and it has reached North Africa and Mexico.
(05 Mar 2000)
machado-joseph disease A progressive degenerative disease of the central nervous system occurring in portuguese-azorean families, having a variety of forms and inherited as an autosomal dominant trait. There are four major types: type I: with pyramidal and extrapyramidal deficits; type II: with cerebellar, pyramidal and extrapyramidal deficits; type III: with cerebellar deficits and distal sensorimotor neuropathy; type IV: with parkinsonism and distal sensory neuropathy. It was originally reported in two portuguese-azorean families in massachusettes (machado), then in another portuguese family (thomas), and later in a third family in california (joseph, who settled there in 1845). It has been reported also in japanese families.
(12 Dec 1998)
Paas' disease A familial skeletal deformation marked by coxa valga, double patella, shortening of the middle and terminal phalanges of fingers and toes, deformities of the elbows, scoliosis, and spondylitis deformans of the lumbar vertebrae; all of these manifestations may be unilateral or bilateral.
(05 Mar 2000)
Gairdner's disease <disease> Attacks of cardiac distress accompanied by apprehension.
Synonym: angina pectoris sine dolore, angor pectoris.
(05 Mar 2000)
Pacheco's disease A highly contagious, acute disease of psittacine birds caused by a herpesvirus and characterised by bright yellow urates with scant faeces, icterus, and terminal anorexia.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á